
Gaming Industry
Eli Lilly’s $6.3 billion deal
Eli Lilly’s $6.3 billion deal on May 2, 2026, signals major pharmaceutical investment, with potential indirect impacts o…
Sarah Chen·
2 articles

Eli Lilly’s $6.3 billion deal on May 2, 2026, signals major pharmaceutical investment, with potential indirect impacts o…

Novo Nordisk’s CagriSema trails Eli Lilly’s tirzepatide in weight loss trial. Shares react. FDA decision awaited. Higher…